Fair Access to Stem Cells
Tags: SOCIAL justice; MEDICINE -- Research; STEM cells -- Transplantation; DONATION of organs, tissues, etc.; FEMINISM; BIOETHICS
Related Articles
- Plerixafor 'just in time' for stem cell mobilization in a normal donor. Schriber, J.; Fauble, V.; Sproat, L. O.; Briggs, A. // Bone Marrow Transplantation;Jul2011, Vol. 46 Issue 7, p1026
A letter to the editor is presented regarding the use of plerixafor in the mobilization of stem cells for transplantation using the so-called just in time rescue strategy on a 56-year-old normal donor.
- Sharing Our Body and blood: Organ Donation and Feminist Critiques of Sacrifice. Mongoven, Ann // Journal of Medicine & Philosophy;Feb2003, Vol. 28 Issue 1, p89
Feminist analysis of cultural mythology surrounding organ donation of offers a critical perspective on current U.S. transplant policy. My argument is three-pronged. First, I argue that organ donation is appropriately understood as a sacrifice. Structurally, donation accords both to general and...
- European kidney market. Dorozynski, Alexander // BMJ: British Medical Journal (International Edition);11/11/89, Vol. 299 Issue 6709, p1182
Reports the scandal involving a kidney donor in France. Formulation of a project on bioethics; Characterization of the purchase of organs as criminal; Adoption of a charter to defend ethical principles of voluntary and anonymous organ donation.
- Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: In reply. Zander, R. Axel; Bacher, Ulrike; Finke, J�rgen // Deutsches Aerzteblatt International;2/6/2009, Vol. 106 Issue 6, p1
The authors argue on the study on the transplantation of allogeneic stem cell in acute myeloid leukemia (AML). They say that such study did not prove the relevance of transplantation of HLA identical unrelated donors to sibling donor transplantation. The comparison of dose reduced conditioning...
- Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: Statement Was Not Sufficiently Supported. Herrmann-Frank, Annegret; Koch, Klaus; Lange, Stefan; Sawicki, Peter T. // Deutsches Aerzteblatt International;2/6/2009, Vol. 106 Issue 6, p1
The authors probe the article on allogeneic stem cell transplantation in acute myeloid leukemia (AML) by R. Zander and colleagues. The authors said that the publication being cited failed to mention any comparison of related and unrelated donors. They stress the possibility of stem cell...
- Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Fanin, R; Patriarca, F.; Skert, C.; Sperotto, A.; Damiani, D.; Cerno, M.; Geromin, A.; Zaja, F.; Stocchi, R.; Prosdocimo, S.; Fili, C. // Bone Marrow Transplantation;Apr2004, Vol. 33 Issue 7, p751
Summary:We evaluated the incidence, the risk factors, and the outcome of late-onset noninfectious pulmonary complications (LONIPCs) among 50 patients who underwent allogeneic stem cell transplantation from unrelated donors. Of the 39 patients surviving at least 3 months, 10 (26%) fulfilled the...
- World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries. Hurley, CK; Raffoux, C // Bone Marrow Transplantation;Jul2004, Vol. 34 Issue 2, p103
Summary:World Marrow Donor Association standards are aimed at enhancing the quality of unrelated volunteer donor hematopoietic stem cell registries assisting transplant physicians in the international search for unrelated donors for their patients. The standards cover: (1) general organization...
- Family donor care management: principles and recommendations. van Walraven, S. M.; Nicoloso-de Faveri, G.; Axdorph-Nygell, U. A. I.; Douglas, K. W.; Jones, D. A.; Lee, S. J.; Pulsipher, M.; Ritchie, L.; Halter, J.; Shaw, B. E. // Bone Marrow Transplantation;Aug2010, Vol. 45 Issue 8, p1269
The World Marrow Donor Association (WMDA) is an international organization fostering collaboration in clinical transplantation and promoting the interests of unrelated stem cell donors. The WMDA has developed standards for the recruitment, counseling, work-up and subsequent donations to protect...
- Almost all European countries who belong to EC have provisions requiring tissues, cells be donated voluntarily. // Transplant News;Sep2011, Vol. 21 Issue 9, p5
The article focuses on the "2nd Report on Voluntary and Unpaid Donation of Tissues and Cells" from the European Commission (EC). The report shows that 25 European countries including Italy, France, and Spain integrates unpaid donations in their national regulations, while 13 countries including...
